TB Control Project
The Strengthening Tuberculosis Control in Ukraine project works through specific quality assurance programs and systems strengthening measures for routine health services in targeted areas of the country. The project focuses on a variety of health services in ten targeted regions of Ukraine. The project works to expand the availability of Directly Observed Treatment Short course (DOTS)-based TB services, improve the quality of laboratory practices for correct diagnoses, and introduce infection control practices in health facilities. By promoting safe patient practices, the project also supports health facilities to more effectively manage multi-drug-resistant TB cases and contributes to better treatment outcomes.
This program area covers components of program design and performance management and learning. This area supports assessment, special studies and analysis, strategic planning, program and project design, program monitoring (to include baseline studies and other data collection needs) and activities that support learning, knowledge transfer and adaptation of projects. Assessment includes the examination of the state of a country or sector context to inform project design but does not include evaluation of USG-funded activities (please see Program Area PO.3 for a definition of evaluation). Special studies or analysis could support strategic or project planning or include research for general learning that is not necessarily related to the performance of USG-funded activities. This program area may also include the preparation of strategic plans and other short-term programming tasks, assessment of the potential of information and communication technologies to enhance performance throughout the program cycle or dissemination of best practices and lessons learned. Evaluation is the systematic collection and analysis of information about the characteristics and outcomes of programs and projects as a basis for judgments, to improve effectiveness and inform decisions about current and future programming. Evaluations are distinct from (a) needs assessments, which are designed to examine country or sector context to inform project design, (b) internal informal reviews of projects and (c) audits (conducted either internally or by an external audience). Such efforts should not be included in PO.3. However, evaluability assessments -- those assessments completed with the purpose of determining whether or not an evaluation of an activity can be conducted -- should be included in PO.3. This program area should include all evaluations designed and funded with foreign assistance funding, including the components of contracts with task orders for evaluations (regardless of the mechanism). It should also include all independent contractors hired solely to produce an evaluation(s); all other contractors (e.g., those whose job responsibilities may include support or management of evaluation but not the production of an evaluation as a deliverable) should be placed in PO.2. Contribute to a 50% reduction in TB mortality and prevalence (compared to 1990 levels) by accelerating detection of TB cases and by successfully treating detected cases, as well as scaling up programmatic management of multidrug-resistant TB (MDR-TB), expanding coverage of TB/HIV interventions in coordination with PEPFAR and strengthening health systems.
- Project ID
US-GOV-1-LR-AID-GHS-I-00-03-00034
- Activity status
- 3 - Completion
- Aid type
- C01 - Project-type interventions
- % to Liberia
- 100.00
Organisations
- Accountable
- U.S. Agency for International Development
- Extending
- U.S. Agency for International Development
- Funding
- U.S. Agency for International Development
- Implementing
- PATH
Disbursements by fiscal year, quarter
Fiscal year |
Fiscal quarter |
Value (USD) |
Liberia Value (USD) |
2014 |
Q1 |
21,402.00 |
21,402.00 |
2011 |
Q4 |
967,058.57 |
967,058.57 |
2011 |
Q3 |
165,174.43 |
165,174.43 |
2011 |
Q2 |
1,812,374.47 |
1,812,374.47 |
2011 |
Q1 |
847,879.25 |
847,879.25 |
2010 |
Q4 |
1,732,148.42 |
1,732,148.42 |
2010 |
Q3 |
1,906,284.57 |
1,906,284.57 |
2010 |
Q2 |
2,846,672.85 |
2,846,672.85 |
2010 |
Q1 |
560,361.21 |
560,361.21 |
2009 |
Q4 |
2,006,071.54 |
2,006,071.54 |
2009 |
Q3 |
652,286.08 |
652,286.08 |
2009 |
Q2 |
2,060,344.36 |
2,060,344.36 |
2009 |
Q1 |
2,380,471.01 |
2,380,471.01 |
2008 |
Q4 |
1,485,542.93 |
1,485,542.93 |
2008 |
Q3 |
1,439,118.35 |
1,439,118.35 |
2008 |
Q2 |
948,298.20 |
948,298.20 |
2008 |
Q1 |
539,470.71 |
539,470.71 |
2007 |
Q4 |
371,873.53 |
371,873.53 |
2007 |
Q3 |
638,300.93 |
638,300.93 |
2007 |
Q2 |
503,739.60 |
503,739.60 |
Commitments by fiscal year, quarter
Fiscal year |
Fiscal quarter |
Value (USD) |
Liberia Value (USD) |
2014 |
Q1 |
21,402.00 |
21,402.00 |
2013 |
Q3 |
-21,402.00 |
-21,402.00 |
2013 |
Q1 |
-21,402.00 |
-21,402.00 |
2012 |
Q2 |
21,402.00 |
21,402.00 |
2011 |
Q3 |
296,130.00 |
296,130.00 |
2011 |
Q2 |
113,870.00 |
113,870.00 |
2010 |
Q4 |
360,000.00 |
360,000.00 |
2010 |
Q1 |
2,927,250.00 |
2,927,250.00 |
2009 |
Q1 |
6,535,506.00 |
6,535,506.00 |
2008 |
Q1 |
9,607,000.00 |
9,607,000.00 |
MTEF projections by fiscal year
Fiscal year |
Value (USD) |
Liberia Value (USD) |
CRS code |
% |
STD control including HIV/AIDS
(13040)
|
0.02
|
Unknown
(0)
|
100.0
|
Decentralisation and support to subnational government
(15112)
|
-0.11
|
Multisector aid
(43010)
|
0.08
|